NeuroSense Therapeutics Ltd.

NRSN · NASDAQ
Analyze with AI
$0.8364−$0.0536 (−6.02%)
At close:Dec 15, 2025, 8:59 PM UTC
$0.84+$0.0036 (+0.43%)
After hours:Dec 15, 2025, 10:18 PM UTC
P/E TTM-2.45
P/B TTM-40.94
P/S TTM0
Dividend Yield0%
EPS-$0.36
Beta1.563
Valuation
PEG Ratio0.16
FCF Yield-0.01%
EV / EBITDA-2.33
More On Valuation »
Quality
ROIC1,651.25%
Gross Margin0.00%
Cash Conv. Ratio0.23
More On Quality »
Growth
Revenue 3Y CAGR–
FCF Growth-20.94%
More On Growth »
Safety
Net Debt / EBITDA0.08
Interest Coverage-97.39
More On Safety »
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle0.00
More On Efficiency »

NeuroSense Therapeutics Ltd. (NRSN) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is NeuroSense Therapeutics Ltd. (NRSN) stock price today?

As of Dec 15, 2025, 8:59 PM UTC, NeuroSense Therapeutics Ltd. (NRSN) stock is trading at $0.8364. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date NRSN stock quotes for informed trading decisions.

What is NeuroSense Therapeutics Ltd.'s market capitalization?

NeuroSense Therapeutics Ltd. (NRSN) has a market capitalization of approximately $20.6M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare NeuroSense Therapeutics Ltd.'s size relative to other companies in the USD market. The market cap figure updates automatically as the NRSN stock price changes.

What is the 52-week range for NeuroSense Therapeutics Ltd. stock?

NeuroSense Therapeutics Ltd. (NRSN) stock has traded in a 52-week range of $0.81 — $2.60. The 52-week range shows the highest and lowest prices at which NRSN traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current NeuroSense Therapeutics Ltd. stock price to this range provides context for recent price action.

How much trading volume does NeuroSense Therapeutics Ltd. stock have?

NeuroSense Therapeutics Ltd. (NRSN) stock recently traded approximately 403.4K shares. Trading volume indicates market liquidity and investor interest in NRSN. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting NeuroSense Therapeutics Ltd. stock.

Does NeuroSense Therapeutics Ltd. pay dividends to shareholders?

Yes, NeuroSense Therapeutics Ltd. (NRSN) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate NeuroSense Therapeutics Ltd. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is NeuroSense Therapeutics Ltd.'s intraday price range?

Today, NeuroSense Therapeutics Ltd. (NRSN) stock has traded in a range of $0.8223 — $0.899. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring NRSN's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get NeuroSense Therapeutics Ltd. stock data?

AlphaPilot sources real-time NRSN stock quotes, fundamental financial data, and historical price charts for NeuroSense Therapeutics Ltd. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The NeuroSense Therapeutics Ltd. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of NRSN stock performance.